Nipramef-P Tablet
Marketer
Sapient Laboratories Pvt Ltd
Salt Composition
Mefenamic Acid (500mg) + Paracetamol (325mg)
Overview Nipramef-P Tablet
Combiflame-P tablets contain a dual-action formula effective in reducing fever. This medication also provides relief from mild to moderate pain associated with headaches, muscle aches, and toothaches. For optimal absorption and to minimize stomach upset, take Combiflame-P with food. Dosage varies depending on the condition being treated and individual response; always follow your physician's instructions. Exceeding the recommended dose or duration is strongly discouraged. Potential side effects include nausea, vomiting, diarrhea, dyspepsia, anorexia, and pyrosis. Consult your doctor if any side effects worsen or become bothersome; management strategies may be available. Prior to commencing treatment, inform your physician of any pre-existing conditions, such as peptic ulcers, gastrointestinal bleeding, hypertension, or cardiac, renal, or hepatic impairment. Complete disclosure of all other medications currently being taken is essential due to potential interactions.
Uses of Nipramef-P Tablet
Alleviating pain and reducing fever.
Major Benefits of Nipramef-P Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Nipramef-P Tablets should be administered with a meal.
Common Side effects of Nipramef-P Tablet:
- Nausea
- Vomiting
- Diarrhea
- Indigestion
- Loss of appetite
- Heartburn
How to use Nipramef-P Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Nipramef-P should be administered with a meal.
How Nipramef-P Tablet works:
Nipramef-P tablets combine mefenamic acid and paracetamol to alleviate fever, pain, and inflammation. This dual-action formulation inhibits the production of inflammatory mediators responsible for these symptoms.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Nipramef-P Tablet and alcohol is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Use of Nipramef-P Tablet during pregnancy may pose risks. While human research is insufficient, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Nipramef-P Tablet poses minimal risk during lactation. Research in humans indicates negligible transfer into breast milk, presenting no appreciable danger to the infant.
DrivingUNSAFE
Taking Nipramef-P Tablets might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Nipramef-P Tablets, as dose modification may be necessary. Severe kidney disease contraindicates the use of Nipramef-P Tablets; physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Nipramef-P Tablets cautiously, potentially requiring dosage modification under medical supervision. Nipramef-P Tablets are contraindicated for individuals with severe or active liver disease.
What if you forget to take Nipramef-P Tablet :
Should you forget a Nipramef-P Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Nipramef-P Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Pain Relievers |



